Effect of wet milling process on the solid state of indomethacin and simvastatin

International Journal of Pharmaceutics

Volumn 380, Issue 1-2, 2009, Pages 40-48

  Sharma, Puneet ^a   Denny, William A ^b   Garg, Sanjay ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

High pressure homogenization; Indomethacin; Milling; Solid state transformation; Wet milling

Indexed keywords

INDOMETACIN; POLOXAMER; POVIDONE; SIMVASTATIN;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STABILITY; DRUG STRUCTURE; INFRARED SPECTROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLID STATE; TABLET MANUFACTURE;

CRYSTALLIZATION; DRUG STABILITY; EXCIPIENTS; INDOMETHACIN; MOLECULAR STRUCTURE; NANOPARTICLES; PARTICLE SIZE; POLOXAMER; POVIDONE; SIMVASTATIN; SUSPENSIONS; TECHNOLOGY, PHARMACEUTICAL;

EID: 69549107526     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.06.029     Document Type: Article

References (25)

1. Anon., 2006. Indomethacin Monograph No. 04968. In: O'Neil, M.J., Heckelman, P.E., Koch, C.B., Roman, K.J. (Eds.), The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals. Merck & Co., Inc., New Jersey.
2. g drug: in vitro and in vivo evaluations. Pharm. Res. 22 (2005) 990-998
3. Bahl D., and Bogner R.H. Amorphization of indomethacin by co-grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism. Pharm. Res. 23 (2006) 2317-2325
4. Buckton G., and Darcy P. Assessment of disorder in crystalline powders-a review of analytical techniques and their application. Int. J. Pharm. 179 (1999) 141-158
5. Bugay D.E. Characterization of the solid-state: spectroscopic techniques. Adv. Drug Deliv. Rev. 48 (2001) 43-65
6. Chokshi R.J., Sandhu H.K., Iyer R.M., Shah N.H., Malick A.W., and Zia H. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion process as a means to manufacture solid dispersion/solution. J. Pharm. Sci. 94 (2005) 2463-2474
7. Crowley K.J., and Zografi G. Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability. J. Pharm. Sci. 91 (2002) 492-507
8. Graeser K.A., Strachan C.J., Patterson J.E., Gordon K.C., and Rades T. Physicochemical properties and stability of two differently prepared amorphous forms of simvastatin. Cryst. Growth Des. 8 (2008) 128-135
9. Guinot S., and Leveiller F. The use of MTDSC to assess the amorphous phase content of a micronized drug substance. Int. J. Pharm. 192 (1999) 63-75
10. Hecq J., Deleers M., Fanara D., Vranckx H., and Amighi K. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int. J. Pharm. 299 (2005) 167-177
11. Kipp J.E. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int. J. Pharm. 284 (2004) 109-122
12. Lipinski C.A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods 44 (2000) 235-249
13. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46 (2001) 3-26
14. Okumura T., Ishida M., Takayama K., and Otsuka M. Polymorphic transformation of indomethacin under high pressures. J. Pharm. Sci. 95 (2006) 689-700
15. Otsuka M., and Kaneniwa N. A kinetic study of the crystallization process of noncrystalline indomethacin under isothermal conditions. Chem. Pharm. Bull. (Tokyo) 36 (1988) 4026-4032
16. Otsuka M., Matsumoto T., and Kaneniwa N. Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding. Chem. Pharm. Bull. (Tokyo) 34 (1986) 1784-1793
17. Patterson J.E., James M.B., Forster A.H., Lancaster R.W., Butler J.M., and Rades T. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds. J. Pharm. Sci. 94 (2005) 1998-2012
18. Patterson J.E., James M.B., Forster A.H., Lancaster R.W., Butler J.M., and Rades T. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int. J. Pharm. 336 (2007) 22-34
19. Pavia D.L., Lampman G.M., and Kriz G.S. Infrared spectroscopy. In: Pavia D.L., Lampman G.M., and Kriz G.S. (Eds). Introduction to Spectroscopy (2001), Brooks/Cole, Thomson Learning, Inc., Washington 13-101
20. Shakhtshneider T.P., Danede F., Capet F., Willart J.F., Descamps M., Paccou L., Surov E.V., Boldyreva E.V., and Boldyrev V.V. Grinding of drugs with pharmaceutical excipients at cryogenic temperatures. PPPart II. Cryogenic grinding of indomethacin-polyvinylpyrrolidone mixtures. J. Therm. Anal. Calorim. 89 (2007) 709-715
21. Sheth A.R., Lubach J.W., Munson E.J., Muller F.X., and Grant D.J.W. Mechanochromism of piroxicam accompanied by intermolecular proton transfer probed by spectroscopic methods and solid-phase changes. J. Am. Chem. Soc. 127 (2005) 6641-6651
22. Taylor L.S., and Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 14 (1997) 1691-1698
23. Van Eerdenbrugh B., Van den Mooter G., and Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int. J. Pharm. 364 (2008) 64-75
24. g probed with indomethacin polymorphs. J. Phys. Chem. B 110 (2006) 15694-15699
25. Yoshioka M., Hancock B.C., and Zografi G. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J. Pharm. Sci. 83 (1994) 1700-1705